Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.088
+0.008 (0.38%)
Aug 13, 2026, 12:20 PM EDT - Market open

TherapeuticsMD Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.273.021.761.369.962.57
Revenue Growth
27.78%71.61%35.25%-98.14%2619.12%-96.03%
Gross Profit
3.273.021.761.368.571.17
Operating Income
-1.68-4.39-6.11-8.521.19-79.58
Net Income
-0.22-0.57-2.18-10.28112-172.42
Earnings Per Share
-0.03-0.05-0.19-0.7411.96-9.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.197.485.064.3338.0764.91
Total Debt
4.525.125.546.537.37196.33
Net Cash (Debt)
4.672.36-0.48-2.2130.7-131.43
Net Cash Growth
1229.91%-----
Net Cash Per Share
0.400.20-0.04-0.213.28-16.51

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3.12.451.17-23.089.36-55.13
Capital Expenditures
------0.03
Free Cash Flow
3.12.451.17-23.089.36-55.17
Free Cash Flow Growth
201.85%109.74%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%98.00%45.51%
Operating Margin
-51.31%-145.27%-347.08%-654.61%1.70%-3092.77%
Pretax Margin
-8.04%-21.61%-133.05%-594.62%1.54%-3082.20%
Profit Margin
-9.02%-21.61%-131.29%-591.32%1.54%-3082.20%
FCF Margin
94.71%81.20%66.44%-1772.73%13.38%-2144.07%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----0.47-
Forward PE
-25.0925.0925.09--
P/FCF Ratio
7.727.698.48-5.67-
PS Ratio
7.366.245.6319.930.7660.15